HYPOG - Overview: Hypoglycemic Agent Screen, Serum

Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...

IMIPR - Overview: Imipramine and Desipramine, Serum

Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance

IODCU - Overview: Iodine/Creatinine Ratio, Random, Urine

Assessment of iodine toxicity or recent iodine exposure using a random urine collection Monitoring iodine excretion rate as index of replacement therapy

LGBWB - Overview: Globotriaosylsphingosine, Blood

Screening of patients with Fabry disease when a serum specimen is not available This test should not be used for newborn screening followup.

FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine

Detection and confirmation of illicit drug use involving fentanyl

ALCX - Overview: Ethanol, Chain of Custody, Blood

Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication All testing is performed...

FENR - Overview: Fentanyl Screen with Reflex, Random, Urine

Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen

ETGSR - Overview: Ethyl Glucuronide Screen with Reflex, Random, Urine

Screening for drug abuse involving alcohol

PBUCR - Overview: Lead/Creatinine Ratio, Random, Urine

Detecting clinically significant lead exposure, a toxic heavy metal, using random urine specimens

PBU - Overview: Lead, 24 Hour, Urine

Detecting clinically significant lead exposure in 24-hour specimens This test is not a substitute for blood lead screening.